Log In
Print
BCIQ
Print
Print this Print this
 

ONT-10

  Manage Alerts
Collapse Summary General Information
Company Oncothyreon Inc.
DescriptionLiposomal glycolipopeptide cancer vaccine targeting mucin 1 (MUC1; CD227)
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today